Stock MTS MEDICATION TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News MTS Medication Technologies, Inc.

Equities

US5537731029

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for MTS Medication Technologies, Inc.

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MTS Medication Technologies : MACOM and Amphenol Support Ross Video for Industry's First 12G SDI openGear Platform
PU
MTS Medication Technologies : MACOM Announces Industry's First CWDM4 L-PIC™ for 100G Datacenter Applications
PU
MTS Medication Technologies : MACOM Showcases Industry's Broadest Portfolio of RF to Light Solutions for Wireless Network Infrastructure
PU
MTS Medication Technologies : MACOM SPARTM Tiles Selected by Massachusetts Institute of Technology's Lincoln Laboratory as Testbed for the DARPA ACT Radar Development Program
PU
MTS Medication Technologies : MACOM's 12G Chipset Selected for Marshall Electronics' New 12G-SDI Broadcast Converters
PU
MTS Medication Technologies : MACOM Completes Divestiture of Automotive Business
PU
MTS Medication Technologies : MACOM to Showcase Optical Portfolio Solutions at CIOE 2015 in Shenzhen, China from August 31 - September 3, 2015
PU
MTS Medication Technologies : MACOM Announces Fourth Generation GaN Technology
PU
MACOM Announces Upsize and Pricing of Public Offering of Common Stock
GL
MACOM Announces Proposed Public Offering of Common Stock
GL
MACOM Reports Revenue of $114.9 Million With EPS $0.38 and Gross Margin of 53.7 Percent (Non-GAAP)
GL
MACOM to Present at the Stifel Technology, Internet and Media Conference on February 10
GL
MACOM to Announce First Quarter Fiscal 2015 Financial Results on February 2, 2015
GL
MACOM to Present at the Needham Growth Conference on January 13
GL
MACOM Successfully Completes Acquisition of BinOptics Corporation
GL
MACOM to Participate at the Barclays Global Technology Conference on December 9
GL
MACOM Reports Strong Growth; Revenue of $114.3 Million With EPS of $0.35 and Gross Margin of 54.1 Percent (non-GAAP)
GL
MACOM Announces Definitive Agreement to Acquire BinOptics Corporation
GL
MACOM to Announce Fourth Quarter Fiscal 2014 Financial Results on November 18, 2014
GL
MTS Medication Technologies : MACOM Announces Industry's Leading Up-Converter for 28 - 34 GHz Point-to-Point Radio Applications
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News MTS Medication Technologies, Inc.